Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Triple Negative Breast Neoplasms
×
glembatumumab vedotin
×
Clear all
Filters
3
NCT01997333
2019-03-08
METRIC
Celldex Therapeutics
Phase 2
Completed
327 enrolled
17 charts